You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MLYS Exercise Disclosure
Rodman David Malcom · SEC Form 4 · Filed Jun 12, 2026
Exercise
Calculated transaction value
$6.86K
Rodman David Malcom Chief Medical Officer
MLYS
Transaction date
Jun 12, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed same day
MLYS daily price context
Close on/before transaction
$23.62
Jun 12, 2026
First close after public filing
$23.92
Jun 15, 2026
30-day return after filing
+15.34%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,349 shares @ $1.08
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001672659-26-000030
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$247.73K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Mineralys Therapeutics, Inc. MLYS Current | Exercise | Jun 12, 2026 | $6.86K |
| Mineralys Therapeutics, Inc. MLYS | Sale | Jun 12, 2026 | $151.9K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 12, 2026 | $0 |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 10, 2026 | $34.72K |
| Mineralys Therapeutics, Inc. MLYS | Sale | Jun 10, 2026 | $54.25K |
| Mineralys Therapeutics, Inc. MLYS | Exercise | Jun 10, 2026 | $0 |